Xeloda Tablets, 150mg and 500mg, USP are indicated as a treatment of metastatic breast and colorectal cancers.
Pursuant to the agreement, the litigation was dismissed on 21 September 2011.
Further, the terms of the agreement were not disclosed.
Xeloda Tablets, 150mg and 500mg, USP are indicated as a treatment of metastatic breast and colorectal cancers.
Pursuant to the agreement, the litigation was dismissed on 21 September 2011.
Further, the terms of the agreement were not disclosed.